Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,351 public trials 332 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 280 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

NCT06345729

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CBCC Global Research, Inc. ( Site 0123) Bakersfield, California, United States
  • Beverly Hills Cancer Center ( Site 0116) Beverly Hills, California, United States
  • Stamford Hospital ( Site 0136) Stamford, Connecticut, United States
  • Mount Sinai Cancer Center ( Site 0137) Miami Beach, Florida, United States
View all 225 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

NCT05789082

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope - Seacliff Huntington Beach, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
View all 71 locations
View Trial Details
Recruiting

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06236438

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Hospital West /ID# 262221 Pembroke Pines, Florida, United States
  • Bond Clinic /ID# 262611 Winter Haven, Florida, United States
  • The University of Chicago Medical Center /ID# 262259 Chicago, Illinois, United States
  • University of Kansas Medical Center /ID# 263196 Westwood, Kansas, United States
View all 61 locations
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

NCT07659782

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • START LA Los Angeles, California, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START Fort Worth Fort Worth, Texas, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

NCT07361562

Conditions
Advanced Solid Tumor, Adult, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • NYU Langone New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • NEXT Oncology Texas Austin, Texas, United States
View all 15 locations
View Trial Details
Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

NCT06712316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology Birmingham, Alabama, United States
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • John Muir Clinical Research Center Concord, California, United States
  • University Of California - San Diego Moores Cancer Center La Jolla, California, United States
View all 262 locations
View Trial Details

Related conditions